GLB-001

A First-in-human, Phase 1, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Arms / Cohorts

Experimental:Dose Escalation: GLB-001 - AML Patients

Accepting patients

Experimental:Dose Escalation: GLB-001 - MDS Patients

Accepting patients

Experimental:Dose Expansion: GLB-001 - MDS Patients

Not yet accepting

Experimental:Dose Expansion: GLB-001 - AML Patients

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.